Vitamin D deficiency is common in multiple sclerosis (MS) patients. This review explores the potential benefits and limitations of high-dose vitamin D supplementation in MS management. We reviewed relevant literature on the effects of high-dose vitamin D supplementation on relapse rates, disability progression, quality of life, and MRI markers of disease activity in MS patients. Additionally, we discussed the mechanisms by which vitamin D might influence MS, potential adverse effects, and future research directions. Studies suggest that high-dose vitamin D supplementation may reduce relapse rates and improve MRI markers of disease activity in MS. However, the evidence for its impact on disability progression and quality of life remains inconclusive. Vitamin D’s immunomodulatory properties are well-documented, and its potential for neuroprotection and neurogenesis warrants further investigation. High-dose vitamin D supplementation holds promise as a complementary or disease-modifying therapy for MS. However, further robust research is required to solidify its role in clinical practice. Exploring vitamin D’s multifaceted effects on the immune system, neuroprotection, and neurogenesis paves the way for novel therapeutic strategies to improve the lives of individuals with MS.
Moyamoya disease is a rare cerebrovascular disease that occurs due to narrowing and blockage of the internal carotid arteries and their associated branches resulting in the development of additional collateral vessels. Although the prevalence is higher in Asian countries, there have been documented increases in occurrence globally—the consequences of Moyamoya range from chronic headaches to neurocognitive impairment. Endovascular techniques have emerged as a potential option for managing MMD, particularly for individuals who are unsuitable candidates for direct surgical revascularization or have already undergone such procedures. Various endovascular techniques, such as coiling, stenting, and angioplasty have been used in managing Moyamoya disease. To enhance the safety and efficacy of these interventions, multimodal techniques that combine various endovascular methods are currently being used and studied in clinical trials. This review aims to provide a comprehensive assessment of existing endovascular techniques as well as highlight areas for future development. By reviewing these techniques, a comprehensive analysis of their safety, efficacy, and long-term outcomes was provided in the study. Comparatively, embolization, particularly onyx embolization remains the gold standard for MMD treatment as it provides a more definitive and long-term solution by addressing MMD-associated complications with little to no adverse events. Overall, endovascular techniques showed varying results with some interventions being safer and more effective than others.